Core Laboratories NV (CLB)
Debt-to-capital ratio
Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | ||
---|---|---|---|---|
Long-term debt | US$ in thousands | 163,134 | 177,863 | 182,583 |
Total stockholders’ equity | US$ in thousands | 224,815 | 224,694 | 214,756 |
Debt-to-capital ratio | 0.42 | 0.44 | 0.46 |
December 31, 2023 calculation
Debt-to-capital ratio = Long-term debt ÷ (Long-term debt + Total stockholders’ equity)
= $163,134K ÷ ($163,134K + $224,815K)
= 0.42
The debt-to-capital ratio for Core Laboratories NV has been progressively decreasing over the three most recent quarters. In this period, the ratio has declined from 0.46 in June 30, 2023, to 0.42 in December 31, 2023. This trend indicates that the company has been reducing its reliance on debt financing in relation to its capital structure. Lower debt-to-capital ratios generally suggest lower financial risk and greater stability for the company, as it indicates a larger proportion of the company's capital is funded through equity rather than debt. This could be a positive sign for investors and creditors, as it may imply improved financial health and a stronger ability to meet its financial obligations in the long run.
Peer comparison
Dec 31, 2023